Simultaneous Administration of EZH2 and BET Inhibitors Inhibits Proliferation and Clonogenic Ability of Metastatic Prostate Cancer Cells

The authors tested, for the first time, the combination of an Enhancer of Zeste 2 (EZH2) inhibitor with a BET inhibitor in metastatic prostate cancer cells.